Thrive Capital Management, LLC Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001765681
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q2 2025 · 3 positions · Total reported value $236.06M · Top-10 concentration 100.0% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 16.7% · 1 new · 0 cut · 0 exited
Active Share (vs S&P 500): 97.1% · vs QQQ: 93.5% — share of the book that differs from index weights (higher = more active) · ranking
In its Q2 2025 13F filing, Thrive Capital Management, LLC disclosed 3 equity positions with a combined reported value of $236.06M. The filing implies a focused portfolio: its ten largest positions account for 100.0% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt.
The largest disclosed positions as of Q2 2025 were OSCR ($136.01M), CVNA ($76.41M), VMEO ($23.65M). By sector, the heaviest allocations are Health Care 57.6%, Consumer Discretionary 32.4%. Versus the prior quarter, allocation shifted toward Health Care (+43.5pp), Other (+4.8pp) and away from Consumer Discretionary (-48.1pp).
Versus the prior quarter, Thrive Capital Management, LLC opened 1 new positions, trimmed 0 and fully exited 0, a turnover rate of 16.7% of positions. The portfolio's overlap with the prior quarter was 75% of names.
Of the 1 positions fully exited versus the prior quarter, the largest were AMPL ($872.67K).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q2 2025)
No new positions this quarter.
Fully Exited (vs previous quarter)
- AMPL AMPLITUDE INC · prev qtr: $872.67K
Insider Transactions (Form 4)
Latest Thrive Capital Management, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Thrive Capital Management, LLC is an SEC-registered 13F filer. As of Q2 2026 it reported 5 US equity positions with a combined value of $3.81B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Portfolio Structure
- 5 positions · $3.81B reported value (Q2 2026)
- Top 10 holdings = 100.0% of reported value
- Largest position: SPCX (SPACE EXPLORATION TECHN CORP) at 84.8%
- Average position size: $761.98M
Sector Tilt
- Information Technology 89.6%
- Consumer Discretionary 5.7%
- Health Care 4.7%
- (classified holdings cover 100% of value)
Quarterly Activity
- Q2 2026: 2 new, 2 exited
- 3 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
FAQ
What did Thrive Capital Management, LLC buy in 2025-Q2?
In its 2025-Q2 13F filing, Thrive Capital Management, LLC reported 3 equity positions worth $236.06M in aggregate; its largest disclosed positions were OSCR ($136.01M), CVNA ($76.41M), VMEO ($23.65M).
How large is Thrive Capital Management, LLC's portfolio?
Thrive Capital Management, LLC reported $236.06M of long equity holdings across 3 positions as of 2025-Q2. Top-10 holdings account for 100.0% of reported value.
What is Thrive Capital Management, LLC's investment style?
HoldingsHub classifies the portfolio as Small / Focused / Health Tilt, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.